BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND PTPN11, CFC, Q06124, 5781, ENSG00000179295, SHP2, MGC14433, SHP-2, BPTP3, PTP-1D, SH-PTP3, NS1, SH-PTP2, PTP2C
223 results:

  • 1. [FLT3-ITD mutation-positive acute myeloid leukemia undergoing clonal transition with ptpn11 mutation at relapse].
    Kurihara K; Sadato D; Najima Y; Hirama C; Haraguchi K; Kato K; Kondo K; Sadaga Y; Kato C; Sakai S; Kambara Y; Nabe Y; Teshima K; Asano K; Jinguji A; Shimabukuro M; Ouchi F; Inai K; Koi S; Shingai N; Toya T; Shimizu H; Kobayashi T; Oboki K; Harada H; Okuyama Y; Harada Y; Doki N
    Rinsho Ketsueki; 2024; 65(2):63-68. PubMed ID: 38447999
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mapping the landscape of genetic dependencies in chordoma.
    Sharifnia T; Wawer MJ; Goodale A; Lee Y; Kazachkova M; Dempster JM; Muller S; Levy J; Freed DM; Sommer J; Kalfon J; Vazquez F; Hahn WC; Root DE; Clemons PA; Schreiber SL
    Nat Commun; 2023 Apr; 14(1):1933. PubMed ID: 37024492
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Myeloid sarcoma with
    Ramia de Cap M; Wu LP; Hirt C; Pihan GA; Patel SS; Tam W; Bueso-Ramos CE; Kanagal-Shamanna R; Raess PW; Siddon A; Narayanan D; Morgan EA; Pinkus GS; Mason EF; Hsi ED; Rogers HJ; Toth L; Foucar K; Hurwitz SN; Bagg A; Rets A; George TI; Orazi A; Arber DA; Hasserjian RP; Weinberg OK;
    Leuk Lymphoma; 2023 May; 64(5):972-980. PubMed ID: 36960680
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. shp2 Deficiency in Kupffer Cells and Hepatocytes Aggravates Hepatocarcinogenesis by Recruiting Non-Kupffer Macrophages.
    Du L; Ji Y; Xin B; Zhang J; Lu LC; Glass CK; Feng GS
    Cell Mol Gastroenterol Hepatol; 2023; 15(6):1351-1369. PubMed ID: 36828281
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. IL-6/ERK signaling pathway participates in type I IFN-programmed, unconventional M2-like macrophage polarization.
    Yang L; Guo P; Wang P; Wang W; Liu J
    Sci Rep; 2023 Feb; 13(1):1827. PubMed ID: 36726024
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Case report: Chronic lymphocytic leukemia/small lymphocytic lymphoma and monomorphic epitheliotropic intestinal T-cell lymphoma: A composite lymphoma.
    Zhang B; Zhang Y; Li Q; Jiang Q; Chu W; Gong H; Li R; Ji H
    Pathol Oncol Res; 2022; 28():1610653. PubMed ID: 36567979
    [No Abstract]    [Full Text] [Related]  

  • 7. From Stem to Sternum: The Role of shp2 in the Skeleton.
    Jensen NR; Kelly RR; Kelly KD; Khoo SK; Sidles SJ; LaRue AC
    Calcif Tissue Int; 2023 Apr; 112(4):403-421. PubMed ID: 36422682
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trial.
    Yen R; Grasedieck S; Wu A; Lin H; Su J; Rothe K; Nakamoto H; Forrest DL; Eaves CJ; Jiang X
    Leukemia; 2022 Oct; 36(10):2443-2452. PubMed ID: 35999259
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Phase I Clinical Trial of Prostate-Specific Membrane Antigen-Targeting
    Suh M; Ryoo HG; Kang KW; Jeong JM; Jeong CW; Kwak C; Cheon GJ
    Korean J Radiol; 2022 Sep; 23(9):911-920. PubMed ID: 35762185
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations.
    Eckardt JN; Stölzel F; Kunadt D; Röllig C; Stasik S; Wagenführ L; Jöhrens K; Kuithan F; Krämer A; Scholl S; Hochhaus A; Crysandt M; Brümmendorf TH; Naumann R; Steffen B; Kunzmann V; Einsele H; Schaich M; Burchert A; Neubauer A; Schäfer-Eckart K; Schliemann C; Krause SW; Herbst R; Hänel M; Hanoun M; Kaiser U; Kaufmann M; Rácil Z; Mayer J; Kroschinsky F; Berdel WE; Ehninger G; Serve H; Müller-Tidow C; Platzbecker U; Baldus CD; Schetelig J; Bornhäuser M; Thiede C; Middeke JM
    J Hematol Oncol; 2022 May; 15(1):60. PubMed ID: 35562747
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Phosphorylation of shp2 at Tyr62 Enables Acquired Resistance to shp2 Allosteric Inhibitors in FLT3-ITD-Driven AML.
    Pfeiffer A; Franciosa G; Locard-Paulet M; Piga I; Reckzeh K; Vemulapalli V; Blacklow SC; Theilgaard-Mönch K; Jensen LJ; Olsen JV
    Cancer Res; 2022 Jun; 82(11):2141-2155. PubMed ID: 35311954
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Postzygotic mosaicism of a novel ptpn11 mutation in monozygotic twins discordant for metachondromatosis.
    Rydzanicz M; Glinkowski W; Walczak A; Koppolu A; Kostrzewa G; Gasperowicz P; Pollak A; Stawiński P; Płoski R
    Am J Med Genet A; 2022 May; 188(5):1482-1487. PubMed ID: 35112464
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Imaging flow cytometry reveals a subset of TdT negative T-ALL blasts with very low forward scatter on conventional flow cytometry.
    Rosenberg CA; Bill M; Maguire O; Petersen MA; Kjeldsen E; Hokland P; Ludvigsen M
    Cytometry B Clin Cytom; 2022 Mar; 102(2):107-114. PubMed ID: 34648681
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. shp-2 deletion in CD4Cre expressing chondrocyte precursors leads to tumor development with wrist tropism.
    McNamara JT; Huntington KE; Borys S; Jayasuriya CT; Brossay L
    Sci Rep; 2021 Oct; 11(1):20006. PubMed ID: 34625577
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Prognostic Ability of RAS Pathway-Related Gene Mutations in Patients with Myeloid Neoplasms Treated with Hypomethylating Agents.
    Park HS; Son BR; Shin KS; Byeon S; Kim HK; Yang Y; Jeong Y; Han HS; Lee KH; Kwon J
    Acta Haematol; 2021; 144(6):649-659. PubMed ID: 34233332
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Pediatric myelodysplastic syndrome with inflammatory manifestations: Diagnosis, genetics, treatment, and outcome.
    Yanir AD; Krauss A; Stein J; Steinberg-Shemer O; Gilad O; Lotan SN; Dgany O; Krasnov T; Kodman Y; Feuerstein T; Mardoukh J; Fishman H; Geron I; Yacobovich J; Tamary H; Birger Y; Avrahami G; Izraeli S; Birenboim SB
    Pediatr Blood Cancer; 2021 Oct; 68(10):e29138. PubMed ID: 34019335
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. shp2 drives inflammation-triggered insulin resistance by reshaping tissue macrophage populations.
    Paccoud R; Saint-Laurent C; Piccolo E; Tajan M; Dortignac A; Pereira O; Le Gonidec S; Baba I; Gélineau A; Askia H; Branchereau M; Charpentier J; Personnaz J; Branka S; Auriau J; Deleruyelle S; Canouil M; Beton N; Salles JP; Tauber M; Weill J; Froguel P; Neel BG; Araki T; Heymes C; Burcelin R; Castan I; Valet P; Dray C; Gautier EL; Edouard T; Pradère JP; Yart A
    Sci Transl Med; 2021 Apr; 13(591):. PubMed ID: 33910978
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Therapy-related Myeloid Neoplasms in Children: A Single-institute Study.
    Li G; Holly T; Kelly DR; Reddy V; Mikhail FM; Carroll AJ; Kutny MA
    J Pediatr Hematol Oncol; 2022 Jan; 44(1):e109-e113. PubMed ID: 33625084
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Protein tyrosine phosphatases in multiple myeloma.
    Abdollahi P; Köhn M; Børset M
    Cancer Lett; 2021 Mar; 501():105-113. PubMed ID: 33290866
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Hematopoietic Stem Cell Cultures and Assays.
    Frisch BJ
    Methods Mol Biol; 2021; 2230():467-477. PubMed ID: 33197034
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.